REQUEST A DEMO
Total
USD $0.00
Search more companies

Inmunolab E.C.G.S Sas (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Inmunolab E.C.G.S Sas Profile Updated: June 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Inmunolab E.C.G.S Sas is based in Colombia, with the head office in Bogota D.C.. The enterprise currently operates in the Diagnostic Imaging Centers sector. The company was established on December 26, 2014. There are currently 5 (2023) people employed by Inmunolab E.C.G.S Sas. In its most recent financial highlights, the company reported a net sales revenue drop of 78.16% in 2023. A negative growth of 54.24% was recorded in its total assets. The net profit margin of Inmunolab E.C.G.S Sas increased by 39.9% in 2023.

Headquarters
Kr 86 B 53 98 Sur T 3 Ap 310
Bogota D.C.; Bogota D.C; Postal Code: 0012

Contact Details: Purchase the Inmunolab E.C.G.S Sas report to view the information.

Basic Information
Total Employees:
Purchase the Inmunolab E.C.G.S Sas report to view the information.
Outstanding Shares:
Purchase the Inmunolab E.C.G.S Sas report to view the information.
Incorporation Date:
December 26, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Inmunolab E.C.G.S Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-78.16%
Total operating revenue
-78.16%
Operating profit (EBIT)
-17.51%
Net Profit (Loss) for the Period
-17.51%
Total assets
-54.24%
Total equity
-49.29%
Operating Profit Margin (ROS)
39.9%
Net Profit Margin
39.9%
Return on Equity (ROE)
37.43%
Quick Ratio
0.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?